NDC Compounded Drug 71170-550-25 Norepinephrine; Sodium Metabisulfite
Injection, Solution Intravenous
Compounded Drug Product Information
Frequently Asked Questions
What is the NDC number assigned to Norepinephrine Bitartrate 8mg Added To 250ml Of 0.9% Sodium Chloride?
Norepinephrine Bitartrate 8mg Added To 250ml Of 0.9% Sodium Chloride was assigned by its manufacturer with NDC product code 71170-550. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Norepinephrine Bitartrate 8mg Added To 250ml Of 0.9% Sodium Chloride?
The NDC package code 71170-550-25 was assigned to a 250 mL in 1 BAG of norepinephrine; sodium metabisulfite administered intravenous via injection, solution.
Who manufactures this product?
Norepinephrine Bitartrate 8mg Added To 250ml Of 0.9% Sodium Chloride is manufactured by an outsourced facility and labeled by Apollo Care, Llc. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.